Archives
-
C. albicans EVs Inhibit Hyphal Growth via NRG1 Upregulation
2026-06-03
This study reveals that high concentrations of Candida albicans extracellular vesicles (EVs) suppress hyphal development by upregulating the NRG1 transcriptional repressor. These findings clarify a self-regulatory pathway that limits C. albicans virulence and suggest new targets for antifungal therapy.
-
Ferrostatin-1 (Fer-1): Practical Solutions for Ferroptosis A
2026-06-02
This article delivers scenario-driven guidance for deploying Ferrostatin-1 (Fer-1), SKU A4371, to address real-world challenges in oxidative cell death assays. Drawing on validated protocols and peer-reviewed literature, we highlight how Fer-1 ensures reproducibility, assay sensitivity, and reliable workflow integration for cancer and neurodegenerative disease research.
-
Z-YVAD-FMK: Precision Caspase-1 Inhibitor for Apoptosis Assa
2026-06-02
Z-YVAD-FMK empowers researchers to dissect caspase-1-specific pathways in apoptosis and pyroptosis with unmatched selectivity and workflow reproducibility. Here, we translate bench protocols and troubleshooting strategies into actionable steps for inflammasome activation studies and applied cancer research.
-
Honokiol in Immunometabolic Assays: Protocols, Workflows & T
2026-06-01
Honokiol is redefining immunometabolic research as a robust NF-κB pathway inhibitor and antioxidant, enabling precise modulation of CD8+ T cell activity in cancer and inflammation studies. This guide delivers stepwise protocols, troubleshooting, and insights that bridge bench discovery with translational impact.
-
Amiloride (MK-870): Reliable Ion Channel Modulation for Lab
2026-06-01
This article provides scenario-driven guidance for cell-based assay challenges, demonstrating how Amiloride (MK-870) (SKU BA2768) from APExBIO enables reproducible sodium channel research and endocytosis studies. Each section translates bench-level dilemmas into actionable solutions, referencing protocols and evidence to optimize experimental reliability.
-
Ricin-Induced Necroptosis of Lung Epithelial Cells: Mechanis
2026-05-31
This article examines the mechanistic findings of Kempen et al. (2023), who dissected how ricin toxin, in synergy with inflammatory cytokines, triggers necroptosis in lung epithelial cells via bystander effects. The study clarifies the distinct roles of apoptosis, necroptosis, and inflammatory mediators, informing future inflammasome and cell death pathway research.
-
CD28-ARS2-PKM Axis Enhances CD8+ T Cell Metabolic Flexibilit
2026-05-30
This study reveals how the CD28-ARS2 signaling axis drives alternative splicing of pyruvate kinase to promote PKM2 expression in activated CD8+ T cells, facilitating metabolic flexibility and robust antitumor immunity. The findings highlight a previously unrecognized mechanism linking costimulatory signaling to immune cell metabolic reprogramming, with implications for cancer immunotherapy research.
-
IWP-L6: Porcupine Inhibitor for Precision Wnt Pathway Modula
2026-05-29
IWP-L6 empowers researchers with sub-nanomolar precision to dissect Wnt signaling dynamics in development, metabolism, and regeneration. Explore actionable workflows, troubleshooting strategies, and translational insights inspired by the latest breakthroughs in Wnt-mediated bone formation.
-
Extracellular Vesicle-Mediated Suppression of Hyphal Growth
2026-05-29
This study reveals that high concentrations of Candida albicans extracellular vesicles (EVs) inhibit hyphal development by upregulating the Nrg1 transcriptional repressor. The findings illuminate a self-regulatory mechanism impacting pathogenicity and candidemia, offering new insights for antifungal strategy development.
-
rhBNP Attenuates Renal Ferroptosis via SCLY-Mediated Seleniu
2026-05-28
This study demonstrates that recombinant human brain natriuretic peptide (rhBNP) protects against renal ischemia-reperfusion injury by inhibiting ferroptosis through upregulation of selenocysteine lyase (SCLY) and enhanced selenium recycling. These findings reveal a novel mechanistic target for acute kidney injury intervention and provide a foundation for improved experimental modeling of renal pathophysiology.
-
ACSL1 Drives Ferroptosis Resistance in Ovarian Cancer Sphero
2026-05-28
This study uncovers how ACSL1 promotes platinum resistance in ovarian cancer by enhancing FSP1 N-myristoylation, resulting in increased ferroptosis resistance. The findings clarify a novel lipid metabolism–driven mechanism underlying antioxidant capacity and cell death regulation in the context of cancer therapy.
-
Ferrostatin-1 (Fer-1): Applied Workflows in Ferroptosis Assa
2026-05-27
Ferrostatin-1 (Fer-1) empowers researchers to selectively inhibit ferroptosis with high sensitivity and reproducibility in cancer biology and neurodegenerative disease models. This guide delivers actionable experimental workflows, troubleshooting insights, and evidence-based protocol enhancements to accelerate translational research using APExBIO’s trusted compound.
-
PHF2 Histone Demethylase Regulates Neuroinflammation in Alzh
2026-05-27
This study identifies PHF2 as a central epigenetic regulator of inflammatory gene expression in Alzheimer’s disease (AD). By demonstrating that PHF2 knockdown reduces neuroinflammation and improves cognitive function in a mouse model, the research highlights PHF2 as a promising therapeutic target for AD and other neuroinflammatory disorders.
-
Tofacitinib Citrate (CP-690550): Precision in JAK3 Research
2026-05-26
Tofacitinib citrate (CP-690550 citrate) offers unmatched selectivity for JAK3, enabling nuanced dissection of immune signaling and endothelial inflammation. This guide presents optimized workflows, protocol parameters, and troubleshooting insights for researchers leveraging this compound in immune regulation and inflammatory disease models.
-
Shufeng Xingbi Therapy Modulates Immunity and Microbiota in
2026-05-26
This study demonstrates that Shufeng Xingbi Therapy (SFXBT) restores Th1/Th2 immune balance and beneficially alters intestinal flora in a rat model of allergic rhinitis (AR). The findings highlight SFXBT’s capacity to alleviate nasal inflammation by regulating immune signaling and microbiome composition, offering mechanistic insights relevant to translational immunology.